## Disease Overview

Benign mammary neoplasms are common in companion animals, particularly female dogs. These tumors arise from the abnormal growth and reproduction of cells that make up the breast tissue. While most benign mammary tumors remain small and non-invasive, some may progress to become malignant over time. [1]

The risk of developing benign mammary tumors is strongly associated with reproductive status. Intact female dogs, especially those that have not been spayed prior to their first heat, have a significantly higher risk compared to spayed females. Age is also a factor, with the risk increasing as dogs reach 7-11 years old. [1,2] Certain breeds, such as Chihuahuas, Poodles, and Cocker Spaniels, appear to be predisposed. [1] 

Benign mammary tumors typically present as small, firm nodules that can be felt along the mammary chain. While these tumors are usually not painful, they may grow larger over time and potentially interfere with the dog's mobility, grooming, and eating. In some cases, the tumor can ulcerate and bleed, leading to complications. [2]

Accurate diagnosis of the tumor type, whether benign or malignant, is critical as it informs the appropriate treatment approach. Surgical excision is the primary treatment for benign mammary tumors, often with good long-term outcomes. Careful monitoring is important, as dogs with benign tumors remain at risk of developing new tumors, some of which may be malignant. [1]

### Sources
[1] VCA Animal Hospitals. (n.d.). Benign Mammary Tumors in Dogs. https://vcahospitals.com/know-your-pet/mammary-tumors-in-dogs-benign
[2] Companion Animals Extension. (2019). Mammary Tumors in Rats. https://companion-animals.extension.org/mammary-tumors-in-rats/

## Common Pathogens

While certain viral or bacterial infections have been linked to an increased risk of benign breast conditions, the evidence is limited. The main pathogens that may contribute to the development of benign mammary neoplasms include:

Mouse Mammary Tumor Virus (MMTV): MMTV is a retrovirus that causes breast cancer in mice and has been detected in some human breast cancer specimens as well. Studies have shown that MMTV sequences are significantly more prevalent in human breast cancers compared to normal and benign breast tissue controls [1,2]. This suggests MMTV may play a role in the development of certain benign breast conditions that can progress to malignancy.

Human Papillomavirus (HPV): High-risk HPV types have also been associated with an increased risk of benign breast conditions and breast cancer. Several meta-analyses have reported that the prevalence of high-risk HPV is higher in breast cancer samples compared to normal breast tissue [3,4]. However, the exact relationship between HPV and benign breast disease remains unclear.

Other pathogens that have been investigated, but with less conclusive evidence, include Epstein-Barr virus (EBV) and bovine leukemia virus (BLV) [5-7]. Overall, while these viral agents may contribute to the development of some benign breast conditions, more research is needed to fully understand their specific roles and mechanisms.

### Sources
[1] Wang FL, et al. Prevalence and characteristics of mouse mammary tumor virus-like virus associated breast cancer in China. Infect Agent Cancer. 2021;16:47.
[2] Awan UA, et al. An updated systemic review and meta-analysis on human papillomavirus in breast carcinogenesis. Front Oncol. 2023;13:1219161.
[3] Agolli A, et al. Epstein-Barr viral infection and the risk for breast Cancer: a systematic review. Int J Hematol Oncol Stem Cell Res. 2023;17(2):114–24.
[4] Khatami A, et al. Bovine Leukemia virus (BLV) and risk of breast cancer: a systematic review and meta-analysis of case-control studies. Infect Agent Cancer. 2020;15:48.
[5] Johal H, et al. DNA of mouse mammary tumor virus-like virus is present in human tumors influenced by hormones. J Med Virol. 2010;82(6):1044–50.
[6] Goubran M, et al. Isolation of a human betaretrovirus from patients with primary biliary cholangitis. Viruses. 2022;14(5):886.
[7] Syed H, et al. Linking human betaretrovirus with autoimmunity and liver disease in patients with primary biliary cholangitis. Viruses. 2022;14(9):1941.

### Sources
[1] Wang FL, et al. Prevalence and characteristics of mouse mammary tumor virus-like virus associated breast cancer in China. Infect Agent Cancer. 2021;16:47.
[2] Awan UA, et al. An updated systemic review and meta-analysis on human papillomavirus in breast carcinogenesis. Front Oncol. 2023;13:1219161.
[3] Agolli A, et al. Epstein-Barr viral infection and the risk for breast Cancer: a systematic review. Int J Hematol Oncol Stem Cell Res. 2023;17(2):114–24.
[4] Khatami A, et al. Bovine Leukemia virus (BLV) and risk of breast cancer: a systematic review and meta-analysis of case-control studies. Infect Agent Cancer. 2020;15:48.

## Clinical Symptoms and Signs

Benign mammary neoplasms can present with a variety of clinical symptoms and signs. Some common features include:

Palpable breast mass: Benign tumors like fibroadenomas and intraductal papillomas often present as a palpable, mobile, well-defined mass in the breast tissue. The mass may be painless or cause minimal discomfort. [1,2]

Nipple discharge: Intraductal papillomas can cause a serous or bloody nipple discharge, especially from a single duct. The discharge may be spontaneous or expressed with palpation. [1,3]

Skin changes: Certain benign lesions like fat necrosis may cause skin dimpling, discoloration, or fixation to the underlying tissue. Inflammatory processes like duct ectasia can lead to skin erythema and thickening. [1,2]

Asymmetry or enlargement: Rapid growth of a benign tumor like a fibroadenoma or phyllodes tumor may lead to noticeable asymmetry or enlargement of the affected breast. [2,4]

Axillary lymphadenopathy: Benign processes like mastitis or intraductal papillomas can cause palpable lymph nodes in the axilla, though these are typically soft and mobile. [3]

Importantly, many benign breast lesions may be entirely asymptomatic and discovered incidentally on routine breast examination or imaging. Overall, a thorough history and physical exam are critical to characterize the clinical presentation and guide further diagnostic workup.

### Sources
[1] Benign Breast Disease | PPT - SlideShare. https://www.slideshare.net/slideshow/benign-breast-disease/15209651
[2] Palpable breast lumps: An age-based approach to evaluation and diagnosis. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC9575372/
[3] Benign Papilloma of the Breast - PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC5528917/
[4] Benign Breast Diseases: Classification, Diagnosis, and Management. https://academic.oup.com/oncolo/article/11/5/435/6397103

### Sources
[1] https://www.slideshare.net/slideshow/benign-breast-disease/15209651
[2] https://pmc.ncbi.nlm.nih.gov/articles/PMC9575372/
[3] https://pmc.ncbi.nlm.nih.gov/articles/PMC5528917/
[4] https://academic.oup.com/oncolo/article/11/5/435/6397103

## Diagnostic Methods

Breast imaging plays a crucial role in the evaluation of benign breast lesions. The diagnostic approach typically involves a combination of clinical evaluation, laboratory testing, and various imaging modalities.

### Clinical Evaluation
A thorough clinical breast examination is the first step in evaluating a palpable breast mass. The physician should assess the characteristics of the mass, including its size, texture, mobility, and relationship to the surrounding tissues. The presence of any skin changes, nipple discharge, or lymphadenopathy should also be noted.

### Laboratory Testing
In cases where nipple discharge is present, laboratory testing such as cytological evaluation of the discharge or hormonal analysis (e.g., prolactin, thyroid-stimulating hormone) may be warranted to investigate the underlying cause.

### Imaging Modalities
The choice of imaging modality depends on the patient's age and the characteristics of the breast mass.

#### Ultrasonography
Ultrasonography is often the initial imaging test of choice, particularly in younger women with dense breast tissue. It can effectively distinguish between solid and cystic lesions, and it can also guide biopsy procedures.

#### Mammography
Mammography is the primary imaging modality for evaluating breast masses in women over the age of 40. It can detect microcalcifications and other subtle abnormalities that may not be palpable on clinical examination.

#### Magnetic Resonance Imaging (MRI)
MRI is rarely used as a primary imaging tool for benign breast lesions, but it may be considered in specific situations, such as when there is a strong family history of breast cancer or when evaluating the extent of a known lesion.

#### Biopsy
If the clinical and imaging findings are inconclusive, a biopsy may be necessary to obtain a definitive diagnosis. This can be performed using fine-needle aspiration, core needle biopsy, or surgical excision, depending on the characteristics of the lesion and the physician's preference.

### Sources
1. [Diagnosis and Management of Benign Breast Disorders - ACOG](https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2016/06/diagnosis-and-management-of-benign-breast-disorders)
2. [Benign Breast Tumours - Diagnosis and Management - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC6381897/)
3. [Spindle cell lesions of the breast: a diagnostic approach - PubMed](https://pubmed.ncbi.nlm.nih.gov/34322734/)

### Sources
[1] Diagnosis and Management of Benign Breast Disorders - ACOG
[2] Benign Breast Tumours - Diagnosis and Management - PMC
[3] Spindle cell lesions of the breast: a diagnostic approach - PubMed

## Treatment Options

Benign mammary neoplasms have several treatment options available, including medical management, surgical intervention, and supportive care.

For papillomas, surgical excision is generally recommended, especially for peripheral multiple intraductal lesions and atypical papillomas diagnosed through intraductal breast biopsy [1]. In younger patients with nipple discharge from a single duct, a minimal surgical intervention like a microreductomy may be sufficient. Older patients may benefit from radical duct excision to prevent discharge from other ducts and obtain a complete histological assessment [1]. 

For fibroadenomas, a conservative approach with close ultrasound follow-up can be attempted initially, as fibroadenomas often grow slowly and may regress over time [2,3]. Surgical removal or minimally invasive procedures like vacuum-assisted biopsy (VAB) or cryoablation are options if the fibroadenoma increases in size or causes symptoms [2,3]. VAB and cryoablation have shown adequate accuracy and good cosmetic outcomes for benign breast tumors [2,3].

Overall, the management approach depends on the type, size, and location of the benign neoplasm, as well as the patient's risk factors and preferences. Minimally invasive techniques are becoming increasingly common to provide effective treatment with minimal cosmetic impact.

### Sources
[1] Paepke S, Metz S, Brea Salvago A, Ohlinger R. Benign Breast Tumours - Diagnosis and Management. Breast Care (Basel). 2018;13(6):403-412. doi:10.1159/000495919
[2] Benign Breast Tumor: Symptoms, Causes, Diagnosis, Treatment Options. Medicover Hospitals. https://www.medicoverhospitals.in/diseases/benign-breast-tumor/
[3] Benign Breast Tumours - Diagnosis and Management - PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC6381897/

## Preventive Measures

Women with an increased risk of benign mammary neoplasms can take several preventive measures to reduce their risk or the risk of recurrence. These include:

Avoiding risk factors: Older age, personal history of breast cancer or benign breast disease, inherited genetic risk, dense breast tissue, and certain reproductive and hormonal factors can all increase the risk of benign breast neoplasms. Minimizing exposure to these risk factors may help prevent development of these lesions [1,2].

Taking preventive medications: Selective estrogen receptor modulators (SERMs) like tamoxifen and aromatase inhibitors have been shown to significantly lower the risk of benign breast diseases as well as breast cancer in high-risk women [2,3].

Undergoing risk-reducing surgeries: For women at very high genetic risk, bilateral risk-reducing mastectomy can reduce the risk of developing benign and malignant breast neoplasms by up to 90% [3].

Maintaining a healthy lifestyle: Getting regular exercise, maintaining a healthy weight, limiting alcohol intake, and breastfeeding may also help reduce the risk of benign breast lesions [2,4].

Overall, a personalized, multidisciplinary approach is recommended for women at increased risk of benign mammary neoplasms, involving a combination of screening, preventive medications, and potentially risk-reducing surgeries as appropriate [3].

### Sources
[1] Breast cancer risk accumulation starts early - Prevention must also. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079839/
[2] Breast Cancer Prevention: Current Approaches and Future Directions. https://pmc.ncbi.nlm.nih.gov/articles/PMC5939980/
[3] Breast cancer prevention in high-risk women. https://pubmed.ncbi.nlm.nih.gov/31862315/
[4] Breast Cancer Prevention - NCI. https://www.cancer.gov/types/breast/patient/breast-prevention-pdq

## Differential Diagnosis

Benign breast conditions that may present similarly to benign mammary neoplasms and need to be considered in the diagnostic process include:

Papillomas - These are benign epithelial proliferations that can occur in the breast ducts. They may present with nipple discharge or a palpable mass [1]. Distinguishing papillomas from papillary carcinomas can be challenging, especially on imaging. 

Fibroadenomas - These are the most common benign breast tumors, appearing as smooth, well-circumscribed masses on imaging. Some fibroadenomas can have suspicious features that overlap with malignant lesions [2,3].

Phyllodes tumors - These are rare fibroepithelial lesions that can range from benign to malignant. They may present similarly to fibroadenomas on imaging, but tend to be larger and grow more rapidly [4].

It is important to consider these benign breast conditions in the differential diagnosis, as appropriate management may differ from that of malignant lesions. Careful radiologic and pathologic evaluation is crucial to differentiate between benign and malignant neoplasms.

### Sources
[1] Differential diagnosis of benign and malignant breast masses using magnetic resonance imaging: https://pmc.ncbi.nlm.nih.gov/articles/PMC4328303/
[2] Study on the differential diagnosis of benign and malignant breast lesions: https://journals.lww.com/cancerjournal/fulltext/2024/20020/study_on_the_differential_diagnosis_of_benign_and.16.aspx
[3] Differential Diagnosis of Benign and Malignant Breast Papillary Neoplasms on MRI With Non-mass Enhancement: https://www.sciencedirect.com/science/article/pii/S1076633223000673
[4] Benign Breast Tumours - Diagnosis and Management: https://pmc.ncbi.nlm.nih.gov/articles/PMC6381897/

# Benign Mammary Neoplasm

Benign mammary neoplasms are common in companion animals, particularly female dogs. These tumors arise from abnormal breast tissue growth and can present as palpable masses, nipple discharge, or skin changes. Accurate diagnosis is critical, as benign tumors may progress to malignancy over time. Surgical excision is the primary treatment, with minimally invasive techniques becoming more common. Preventive measures like avoiding risk factors and maintaining a healthy lifestyle can also help reduce the risk of these lesions.

## References

| Topic | Key Findings |
| --- | --- |
| Disease Overview | Benign mammary tumors are strongly associated with reproductive status and age in dogs. They typically present as small, firm nodules that may grow larger over time. |
| Common Pathogens | Viruses like mouse mammary tumor virus and human papillomavirus have been linked to an increased risk of benign breast conditions, but more research is needed. |
| Diagnostic Methods | Clinical evaluation, imaging (ultrasound, mammography), and biopsy are used to diagnose benign mammary neoplasms. Minimally invasive techniques like vacuum-assisted biopsy are emerging. |
| Treatment Options | Surgical excision is the primary treatment, with conservative approaches or minimally invasive procedures like cryoablation used in some cases. |
| Preventive Measures | Avoiding risk factors, taking preventive medications, and maintaining a healthy lifestyle can help reduce the risk of benign mammary neoplasms. |

This report provides a comprehensive overview of benign mammary neoplasms in companion animals, covering key aspects from disease characteristics to diagnostic and treatment approaches. Continued research and implementation of preventive strategies are crucial to better manage these common breast conditions.